Medical expenditures of men with hypertension and/or a smoking habit: A 10-year follow-up study of National Health Insurance in Shiga, Japan

Hypertension Research

Volumn 33, Issue 8, 2010, Pages 802-807

  Nakamura, Koshi ^a,b   Okamura, Tomonori ^c   Hayakawa, Takehito ^d   Kanda, Hideyuki ^d   Okayama, Akira ^e   Ueshima, Hirotsugu ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e FUKUJUJI HOSPITAL   (Japan)

Author keywords

epidemiology; medical expenditures; smoking

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEALTH CARE COST; HEALTH STATUS; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREVALENCE; RISK FACTORS; SMOKING;

EID: 77955375851     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.81     Document Type: Article

References (43)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. World Health Organization. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health Organization: Geneva, 2002.
3. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-1518.
4. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
5. Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese\Nippon data 80. J Hum Hypertens 2003; 17: 851-857.
6. Khalili P, Nilsson PM, Nilsson JA, Berglund G. Smoking as a modifier of the systolic blood pressure-induced risk of cardiovascular events and mortality: a population-based prospective study of middle-aged men. J Hypertens 2002; 20: 1759-1764.
7. Shaper AG, Phillips AN, Pocock SJ, Walker M, Macfarlane PW. Risk factors for stroke in middle aged British men. BMJ 1991; 302: 1111-1115.
8. Nakamura K, Huxley R, Ansary-Moghaddam A, Woodward M. The hazards and benefits associated with smoking and smoking cessation in Asia: a meta-analysis of prospective studies. Tob Control 2009; 18: 345-353.
9. Katanoda K, Marugame T, Saika K, Satoh H, Tajima K, Suzuki T, Tamakoshi A, Tsugane S, Sobue T. Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol 2008; 18: 251-264.
10. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, Okamura T, Minowa M, Iimura O. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 2004; 35: 1836-1841.
11. Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens 1990; 8(Suppl 5): S9-15.
12. Janzon E, Hedblad B, Berglund G, Engstrom G. Tobacco and myocardial infarction in middle-aged women: a study of factors modifying the risk. J Intern Med 2004; 256: 111-118.
13. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control 2004; 13: 388-395.
14. Chan M. WHO Report on the Global Tobacco Epidemic 2008: Fresh and Alive. World Health Organization: Geneva, 2008.
15. Yamamoto T, Nakamura Y, Hozawa A, Okamura T, Kadowaki T, Hayakawa T, Murakami Y, Kita Y, Okayama A, Abbott RD, Ueshima H. Low-risk profile for cardiovascular disease and mortality in Japanese. Circ J 2008; 72: 545-550.
16. Hozawa A, Okamura T, Murakami Y, Kadowaki T, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Abbott RD, Okayama A, Ueshima H. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up. Hypertens Res 2007; 30: 1169-1175. (Pubitemid 351176414)
17. Zhang XF, Attia J, D'Este C, Yu XH. Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13.5 years of follow-up. Stroke 2004; 35: 1052-1056. (Pubitemid 38543515)
18. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA 1999; 282: 2149-2155.
19. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, Woodward M. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007; 25: 73-79.
20. Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, Gu DF, Woodward M. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control 2006; 15: 181-188.
21. Woodward M, Martiniuk A, Ying Lee CM, Lam TH, Vanderhoorn S, Ueshima H, Fang X, Kim HC, Rodgers A, Patel A, Jamrozik K, Huxley R. Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. Eur J Cardiovasc Prev Rehabil 2008; 15: 397-401.
22. Asia Pacific Cohort Studies Collaboration. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr 2007; 16: 187-192.
23. Japan Heart Foundation. The Fifth National Survey on Circulatory Disorders. Chuohoki Publishers: Tokyo, 2003 (in Japanese).
24. Hebel JR, McCarter RJ, Sexton M. Health care costs for employed hypertensives. Med Care 1990; 28: 446-457.
25. Nakamura K, Okamura T, Kanda H, Hayakawa T, Kadowaki T, Okayama A, Ueshima H. Impact of hypertension on medical economics: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Hypertens Res 2005; 28: 859-864.
26. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q 1992; 70: 81-125.
27. Izumi Y, Tsuji I, Ohkubo T, Kuwahara A, Nishino Y, Hisamichi S. Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol 2001; 30: 616-623.
28. Health and Welfare Statistics Association. Kokumin Eisei no Doko (Trend for National Health and Hygiene Japan). Health and Welfare Statistics Association: Tokyo, 2004. (in Japanese).
29. Health and Welfare Statistics Association. Hoken to Nenkin no Doko (Trend for Insurance and Pension Japan). Health and Welfare Statistics Association: Tokyo, 2004. (in Japanese).
30. Ito M. Health insurance systems in Japan: a neurosurgeon's view. Neurol Med Chir (Tokyo) 2004; 44: 617-628.
31. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H. Medical costs of patients with hypertension and/or diabetes: a 10-year follow-up study of National Health Insurance in Shiga, Japan. J Hypertens 2006; 24: 2305-2309.
32. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H. Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Eur J Public Health 2007; 17: 424-429. (Pubitemid 350033991)
33. Okamura T, Nakamura K, Kanda H, Hayakawa T, Hozawa A, Murakami Y, Kadowaki T, Kita Y, Okayama A, Ueshima H. of combined cardiovascular risk factors on individual and population medical expenditures: a 10-year cohort study of national health insurance in a Japanese population. Circ J 2007; 71: 807-813.
34. Shiga Prefectural Government. Heisei 2-nendo Shiga-ken Tokeisyo (1990 Data of Shiga Prefecture). Shiga Prefectural Government: Otsu, 1992 (in Japanese).
35. Tamaki J, Ueshima H, Hayakawa T, Choudhury SR, Kodama K, Kita Y, Okayama A. Effect of conventional risk factors for excess cardiovascular death in men: NIPPON DATA80. Circ J 2006; 70: 370-375.
36. The Ministry of Health and Welfare. Manual for Health Check-Ups under Medical Service Law for the Aged. Japan Public Health Association: Tokyo, 1987 (in Japanese).
37. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-687. (Pubitemid 30107623)
38. INTERSALT Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24h urinary sodium and potassium excretion. BMJ 1988; 297: 319-328.
39. Baba S, Pan WH, Ueshima H, Ozawa H, Komachi Y, Stamler R, Ruth K, Stamler J. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans. J Hum Hypertens 1991; 5: 317-332.
40. Elliott P, Stamler J, Dyer AR, Appel L, Dennis B, Kesteloot H, Ueshima H, Okayama A, Chan Q, Garside DB, Zhou B. Association between protein intake and blood pressure: the INTERMAP Study. Arch Intern Med 2006; 166: 79-87.
41. Sekikawa A, Ueshima H, Zaky WR, Kadowaki T, Edmundowicz D, Okamura T, Sutton-Tyrrell K, Nakamura Y, Egawa K, Kanda H, Kashiwagi A, Kita Y, Maegawa H, Mitsunami K, Murata K, Nishio Y, Tamaki S, Ueno Y, Kuller LH. Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors. Int J Epidemiol 2005; 34: 173-179.
42. Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-286.
43. Stamler J, Elliott P, Dennis B, Dyer AR, Kesteloot H, Liu K, Ueshima H, Zhou BF. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens 2003; 17: 591-608.